The Danish drugmaker said the partnerships with Omega Therapeutics and Cellarity Inc. could lead to new treatments for people living with obesity and a type of liver disease known as MASH.
Tag Archive for: cardiometabolic disease
Danish drugmaker Novo Nordisk said it will present new cardiometabolic disease data, including results from its SELECT trial, at the annual American Heart Association Scientific Sessions from Nov. 11-13.